SARS-CoV-2 vaccine and increased myocarditis mortality risk: A population based comparative study in Japan
View ORCID ProfileSintaroo Watanabe, View ORCID ProfileRokuro Hama
doi: https://doi.org/10.1101/2022.10.13.22281036
Sintaroo Watanabe
1Japan Marine United Corporation, Kure Shipyard, Kure, Japan
MD, PhDRokuro Hama
2Non-profit Organization “Japan Institute of Pharmacovigilance (Med Check)”, Osaka, Japan
MD
- Supplemental[supplements/281036_file06.docx]
Posted October 18, 2022.
SARS-CoV-2 vaccine and increased myocarditis mortality risk: A population based comparative study in Japan
Sintaroo Watanabe, Rokuro Hama
medRxiv 2022.10.13.22281036; doi: https://doi.org/10.1101/2022.10.13.22281036
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (719)
- Anesthesia (214)
- Cardiovascular Medicine (3035)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12959)
- Forensic Medicine (12)
- Gastroenterology (848)
- Genetic and Genomic Medicine (4770)
- Geriatric Medicine (440)
- Health Economics (747)
- Health Informatics (3026)
- Health Policy (1095)
- Hematology (405)
- HIV/AIDS (951)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (490)
- Neurology (4544)
- Nursing (242)
- Nutrition (671)
- Oncology (2361)
- Ophthalmology (666)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (296)
- Palliative Medicine (85)
- Pathology (512)
- Pediatrics (1229)
- Primary Care Research (515)
- Public and Global Health (7131)
- Radiology and Imaging (1586)
- Respiratory Medicine (940)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (503)
- Toxicology (63)
- Transplantation (218)
- Urology (187)